Earnings name: Kura Oncology reviews progress with ziftomenib in Q2 2024 By Investing.com
Kura Oncology (NASDAQ:) has supplied a complete replace throughout its second quarter…
Earnings name: Atomera experiences progress throughout sectors, eyes future progress By Investing.com
Atomera Integrated (ATOM) offered a complete replace on its progress and future…
US Federal Reserve chair Jay Powell hails ‘considerable progress’ in tackling inflation
Keep knowledgeable with free updatesMerely signal as much as the US inflation…
